3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
4
Neoplasms
3
Lung Neoplasms
3
Prostatic Neoplasms
2
Lymphoma
2
Colorectal Neoplasms
2
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Substance-Related Disorders
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Papillomavirus Infections
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Leukemia
1
HIV Infections
1
Death
1
Coitus
1
Interventions
Dexamethasone
5
Trimethoprim, Sulfamethoxazole Drug Combination
4
gamma-Globulins
3
Lenalidomide
3
Ciprofloxacin
3
Bortezomib
3
pomalidomide
2
fludarabine phosphate
2
fludarabine
2
elotuzumab
2
carfilzomib
2
Radiotherapy
2
Immunoglobulins, Intravenous
2
Cyclophosphamide
2
Amoxicillin-Potassium Clavulanate Combination
2
siltuximab
1
selinexor
1
nirogacestat
1
iberdomide
1
daratumumab
1
belantamab mafodotin
1
Positron-Emission Tomography
1
Melphalan
1
Interviews as Topic
1
Immunoglobulins
1
Focus Groups
1
Fecal Microbiota Transplantation
1
Clonal Hematopoiesis
1
Clavulanic Acid
1
Chromatin Immunoprecipitation Sequencing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms, Plasma Cell
×
Focus Groups
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled